Diabetes – Global Partnering Deals & Agreements, 2014 to 2019 – ResearchAndMarkets.com

The “Global
Diabetes Partnering 2014 to 2019” report has been added to ResearchAndMarkets.com’s

This report provides understanding and access to partnering deals and
agreements entered into by the world’s leading healthcare companies.

The report provides understanding and access to the partnering deals and
agreements entered into by the world’s leading healthcare companies.

The report provides an analysis of partnering deals. The majority of
deals are discovery or development stage whereby the licensee obtains a
right or an option right to license the licensors technology. These
deals tend to be multicomponent, starting with collaborative R&D, and
commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated
deals terms provides critical insight into the negotiation process in
terms of what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments
clauses, the devil is in the detail in terms of how payments are
triggered – contract documents provide this insight where press releases
do not.

This data driven report contains multiple links to online copies of
actual deals and contract documents as submitted to the Securities
Exchange Commission by companies and their partners, where available.
Contract documents provide the answers to numerous questions about a
prospective partner’s flexibility on a wide range of important issues,
many of which will have a significant impact on each party’s ability to
derive value from the deal.

The initial chapters of this report provide an orientation of partnering

Chapter 1 provides an overview of the trends in partnering since 2014,
including a summary of deals by industry sector, stage of development,
deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the
therapy area, including a comprehensive listing of the deals announced
by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed
and announced since 2014. The chapter is organized by company A-Z, stage
of development at signing, deal type (collaborative R&D, co-promotion,
licensing etc), and technology type. Each deal title links via Weblink
to an online version of the deal record, and where available the
contract document, providing easy access to each contract document on

Chapter 4 provides a listing of partnering deals where a contract
document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2014 where the
acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2014 where the
financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker
needs to know about partnering in the research, development and
commercialization of technologies and products in the therapy area.

The report provides the reader with the following key benefits:

Topics Covered

Executive Summary

Chapter 1 – Therapy partnering trends in numbers

Chapter 2 – Most active dealmakers

Chapter 3 – Partnering deals directory

Chapter 4 – Partnering deals with a contract document

List of Figures

Figure 1: Partnering frequency by yearFigure 2: Partnering most
activeFigure 3: Partnering by industry sectorFigure 4:
Partnering by deal typeFigure 5: Partnering by technology areaFigure
6: Partnering by stage of development

For more information about this report visit https://www.researchandmarkets.com/research/qlbmtl/diabetes_global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190306005305/en/

Leave a Comment